当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析

羚锐制药

(600285)

  

流通市值:127.94亿  总市值:127.94亿
流通股本:5.67亿   总股本:5.67亿

羚锐制药(600285)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.74亿元,每股收益1.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益290158.81万元,未分配利润173653.03万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产488556.26万元,负债198397.45万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,759,116,202.141,906,007,173.3909,046,867.73,311,472,606.54
营业总成本2,132,955,810.671,454,748,169.02696,497,752.042,683,303,531.91
营业利润662,676,665.58476,716,553.34220,826,418.61656,307,235.4
利润总额665,105,059.05479,096,650.48220,820,151.71653,044,169.92
净利润573,907,880413,114,865.4190,328,634.98568,115,699.33
其他综合收益-49,302,213.98-56,954,231.11-49,434,571.49-25,632,363.7
综合收益总额524,605,666.02356,160,634.29140,894,063.49542,483,335.63
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,262,062,502.12,099,554,692.352,949,498,793.692,598,932,741.62
非流动资产合计2,623,500,075.952,614,416,820.842,032,055,523.282,172,984,631.77
资产总计4,885,562,578.054,713,971,513.194,981,554,316.974,771,917,373.39
流动负债合计1,917,993,701.61,939,062,284.831,975,636,840.391,900,159,332.7
非流动负债合计65,980,773.5163,927,964.2364,227,765.7173,061,102.69
负债合计1,983,974,475.112,002,990,249.062,039,864,606.091,973,220,435.39
归属于母公司股东权益合计2,893,837,629.182,703,211,333.732,934,067,847.862,791,040,844.65
股东权益合计2,901,588,102.942,710,981,264.132,941,689,710.882,798,696,938
负债和股东权益合计4,885,562,578.054,713,971,513.194,981,554,316.974,771,917,373.39
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,656,515,780.871,835,882,538.51809,623,301.083,746,939,836.18
经营活动现金流出小计2,306,466,328.621,545,283,321.58764,717,007.292,933,511,087.31
经营活动产生的现金流量净额350,049,452.25290,599,216.9344,906,293.79813,428,748.87
投资活动现金流入小计1,132,711,885.05513,778,335.5240,000,000524,332,662.54
投资活动现金流出小计1,750,214,149.761,122,842,238.1997,440,536.53754,035,208.57
投资活动产生的现金流量净额-617,502,264.71-609,063,902.67-57,440,536.53-229,702,546.03
筹资活动现金流入小计19,592,190.8325,705,891.338,612,408.51102,844,440.21
筹资活动现金流出小计469,975,832.3470,622,535.0220,076,857.67375,578,367.85
筹资活动产生的现金流量净额-450,383,641.47-444,916,643.69-11,464,449.16-272,733,927.64
汇率变动对现金及现金等价物的影响-3,101.422,157.48694.05-2,374.14
现金及现金等价物净增加额-717,839,555.35-763,379,171.95-23,997,997.85310,989,901.06
期末现金及现金等价物余额772,436,452.21726,896,835.611,466,278,009.711,490,276,007.56
最新报告期:2024-12-02
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
招商证券许菲菲1.221.431.662024-12-02
长城证券刘鹏,袁紫馨1.221.481.752024-11-29
招商证券许菲菲1.211.441.712024-11-11
中原证券李琳琳1.281.511.752024-11-07
东方财富证券何玮1.231.431.652024-10-30
TOP↑